Episode 62: Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study
About this episode
This episode discusses a study on the impact of a high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism.
**Paper:** [Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study](https://doi.org/10.1186/s12916-023-03180-3) **Authors:** Wei-Jie Chen, Chun-Xia Gan, Yang-Wei Cai, Yang-Yang Liu, et al. **Journal:** BMC Medicine, 2023 **Why it matters:** Even when catheter ablation successfully restores heart rhythm, microscopic clots can silently lodge in the brain — and this trial tests whether a next-generation cooling catheter actually reduces that hidden risk. --- **Summary** Catheter ablation for atrial fibrillation (AF) — where radiofrequency energy is used to scar the tissue driving abnormal electrical signals — is highly effective, but the heat applied to actively circulating blood can generate micro-emboli (tiny clots and gaseous particles) that travel to the brain. These "silent cerebral embolisms" (SCEs) produce no immediate symptoms yet show up as new lesions on sensitive imaging in a substantial fraction of patients. This trial asked whether a high-power short-duration (HPSD) strategy, delivering 50 W through a Smart Touch Surround Flow (STSF) catheter — which features 56…
People in this episode
Host: Raymond Ruff
Topics covered
- atrial fibrillation
- catheter ablation
- silent cerebral embolism
- high-power short-duration technique
- clinical trial
Keywords
- atrial fibrillation
- ablation technique
- silent cerebral embolism
- micro-emboli
- clinical trial
Mentioned in this episode
Organizations: BMC Medicine
More episodes of Science TLDR
- Episode 63: Engineering of acidic pH-responsive anti-CD3 binding antibodies
- Episode 61: Improving mitochondria and ER stability helps eliminate upper motor neuron degeneration that occurs due to mSOD1 toxicity and TDP‐43 pathology
- Episode 60: A trophoblast glycoprotein specific 5 T4-Vδ2 bispecific T cell engager recruits Vγ9Vδ2-T cells for tumor-selective cytotoxicity across solid malignancies
- A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
- Language models cannot reliably distinguish belief from knowledge and fact
- Spatially organized inflammatory myeloid-CD8+ T cell aggregates linked to Merkel-cell Polyomavirus driven Reorganization of the Tumor Microenvironment
Explore listener stats, chart rankings, contacts and more on the Science TLDR podcast page.